Your browser is no longer supported. Please, upgrade your browser.
Settings
NSPR InspireMD, Inc. daily Stock Chart
NSPR [NYSE]
InspireMD, Inc.
Index- P/E- EPS (ttm)-6.86 Insider Own1.00% Shs Outstand7.34M Perf Week0.00%
Market Cap3.45M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float7.24M Perf Month-9.62%
Income-8.40M PEG- EPS next Q- Inst Own5.80% Short Float7.53% Perf Quarter-32.57%
Sales1.90M P/S1.82 EPS this Y89.40% Inst Trans- Short Ratio1.67 Perf Half Y-80.74%
Book/sh1.95 P/B0.24 EPS next Y- ROA-95.00% Target Price3.00 Perf Year-89.77%
Cash/sh1.17 P/C0.40 EPS next 5Y- ROE-260.90% 52W Range0.43 - 5.63 Perf YTD-81.20%
Dividend- P/FCF- EPS past 5Y43.60% ROI-114.20% 52W High-91.64% Beta1.77
Dividend %- Quick Ratio4.10 Sales past 5Y-1.80% Gross Margin5.80% 52W Low9.30% ATR0.05
Employees34 Current Ratio4.20 Sales Q/Q0.00% Oper. Margin- RSI (14)43.64 Volatility8.06% 12.20%
OptionableNo Debt/Eq0.00 EPS Q/Q90.70% Profit Margin- Rel Volume0.30 Prev Close0.49
ShortableYes LT Debt/Eq0.00 EarningsAug 08 AMC Payout- Avg Volume326.78K Price0.47
Recom2.00 SMA20-8.04% SMA50-11.05% SMA200-70.65% Volume97,176 Change-4.08%
Jan-07-16Initiated Rodman & Renshaw Buy $4
Mar-13-15Downgrade Oppenheimer Outperform → Perform
Nov-26-13Initiated Oppenheimer Outperform $6
Jun-13-17 07:00AM  InspireMD Announces Completion of Transition from Exclusive European Distributor to InspireMD Managed Local Distribution Network Marketwired
Jun-09-17 07:00AM  InspireMD to Present at the 2017 Marcum Microcap Conference Marketwired
Jun-08-17 07:00AM  InspireMD Announces Distribution Agreement for CGuard EPS in Taiwan Marketwired +5.87%
Jun-07-17 07:00AM  InspireMD Announces the Publication of an Investigator Initiated Clinical Registry Reaffirming MGuard(TM) Prime as a Highly Effective Tool to Prevent Heart Damage in Coronary Artery Blockages with High Thrombotic Content Marketwired
Jun-05-17 08:15AM  InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Poland Marketwired
Jun-02-17 08:46AM  InspireMD Announces Appointment of Paul Stuka as Chairman of the Board Marketwired -5.56%
May-31-17 07:55AM  InspireMD to Present at the 6th Annual SeeThruEquity Microcap Investor Conference Accesswire -6.37%
May-30-17 07:00AM  InspireMD Announces First Two Patients in Hong Kong Successfully Treated with CGuard EPS Marketwired +5.21%
May-18-17 09:00AM  InspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case Transmission at EuroPCR 2017 Accesswire -6.76%
May-17-17 08:45AM  InspireMD Announces Publication of the IRON-GUARD Registry in EuroIntervention Accesswire +7.25%
May-15-17 09:10AM  InspireMD Announces Distribution Agreements for CGuard(TM) EPS and MGuard Prime(TM) EPS in Peru and Ecuador Accesswire
May-12-17 11:39AM  InspireMD, Inc. :NSPR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube -5.23%
May-09-17 04:05PM  InspireMD Provides Business Update for the First Quarter of 2017 Accesswire
May-05-17 01:25PM  InspireMD Schedules First Quarter 2017 Earnings Conference Call Accesswire
May-01-17 07:30AM  InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Germany Accesswire
Apr-06-17 07:00AM  InspireMD Announces Distribution Agreement for CGuard(TM) EPS in the Netherlands Accesswire -8.02%
Apr-05-17 04:20PM  InspireMD Announces Listing of Series B Warrants on the NYSE MKT Accesswire -6.74%
Apr-04-17 07:30AM  InspireMD Announces Distribution Agreement for CGuardTM in Turkey Accesswire -7.29%
Mar-30-17 05:04PM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.76%
07:00AM  InspireMD Announces Commercial Launch of CGuard(TM) EPS in the Russian Federation at the ICCA Stroke Event in Moscow Accesswire
Mar-29-17 09:02AM  INSPIREMD, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-23-17 07:00AM  InspireMD's CGuard(TM) Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia Accesswire -11.03%
Mar-22-17 03:38PM  INSPIREMD, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial Statement +13.97%
07:00AM  InspireMD Repays Term Note Ahead of Schedule Accesswire
Mar-21-17 04:44PM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -5.10%
09:23AM  InspireMD, Inc. :NSPR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube
07:00AM  InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Hong Kong Accesswire
Mar-20-17 07:30AM  InspireMD Announces CGuard Distribution Agreement for the Russian Federation Accesswire
Mar-15-17 01:23PM  INSPIREMD, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articles of In
07:30AM  InspireMD Reports Continued Progress in the Transition of European Sales and Distribution Accesswire
06:45AM  Dawson James Securities Announces the Completion of Public Offering with InspireMD Inc. for Gross Proceeds of $6,846,860 Accesswire
Mar-14-17 04:30PM  InspireMD Announces Closing of Public Offering of Approximately $6.8 Million Accesswire -17.65%
02:27PM  InspireMD, Inc. :NSPR-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-09-17 02:24PM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -37.56%
08:37AM  InspireMD Announces Pricing of Public Offering of up to $7.5 Million Accesswire
Feb-22-17 01:04PM  INSPIREMD, INC. Financials -6.10%
Feb-21-17 12:45PM  INSPIREMD, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements -6.98%
Feb-17-17 04:30PM  InspireMD Provides Year End Business Update; Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 Accesswire
Feb-16-17 05:30PM  INSPIREMD, INC. Files SEC form 10-K, Annual Report
04:05PM  InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 Accesswire
Jan-24-17 04:50AM  InspireMD's CGuard(TM) Carotid Embolic Prevention System to be Featured at LINC 2017 Accesswire
Dec-05-16 03:17PM  InspireMD Announces Change in Presentation Time at LD Micro Main Event Conference to Tuesday, December 6 at 4:30PM PT Marketwired
Nov-28-16 04:01PM  InspireMD to Present at LD Micro Main Event on December 6 Marketwired
Nov-17-16 11:51AM  InspireMD, Inc. :NSPR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016
Nov-15-16 07:33AM  INSPIREMD, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -6.75%
Nov-14-16 05:38PM  INSPIREMD, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements
04:10PM  INSPIREMD, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 Marketwired
07:00AM  InspireMD Announces CGuard(TM) Embolic Prevention System Commercialization Approval in Russia Marketwired
Nov-07-16 07:00AM  InspireMD to Report Third Quarter Financial Results on Monday, November 14, 2016 Marketwired -5.12%
Nov-04-16 03:44PM  INSPIREMD, INC. Files SEC form 8-K, Other Events -6.52%
Nov-02-16 06:28AM  INSPIREMD, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits -5.97%
Nov-01-16 02:17PM  Ahead of The Presidential Election, These Stocks Are Hitting New Highs +134.27%
10:35AM  Why InspireMD More Than Doubled at 24/7 Wall St.
09:32AM  InspireMD CGuard(TM) Embolic Prevention System 12-Month Clinical Trial Data Further Validate Potential of CGuard(TM) to Improve Management of Carotid Artery Disease and Prevent Stroke Marketwired
Oct-27-16 04:58PM  INSPIREMD, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and
07:00AM  Long-term Clinical Data on InspireMD's CGuard Embolic Prevention System to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium Marketwired
Oct-26-16 07:00AM  InspireMD Announces Appointment of Medical Device Industry Veteran Agustin Gago as Chief Commercial Officer Marketwired
Oct-20-16 10:28AM  INSPIREMD, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Oct-17-16 11:33AM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -13.21%
11:21AM  Heres Why Monster Worldwide Inc. (MWW), Oceaneering International Inc. (OII) & Three Other Stocks Are Trending Today at Insider Monkey
07:00AM  InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System Marketwired
Oct-13-16 07:00AM  InspireMD to Present at the Dawson James Securities 2nd Annual Growth Stock Conference on October 20 Marketwired
Oct-12-16 11:36AM  Heres Why Traders Are Piling Into These Five Stocks at Insider Monkey +14.81%
Oct-07-16 07:03AM  Splits Calendar: InspireMD splits before market open today (1:25 ratio)
Oct-06-16 04:28PM  INSPIREMD, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Other Events, Financial Stat
04:01PM  InspireMD Announces Adjustments to Shares Receivable Upon Warrant Exercise and Exercise Price per Share Marketwired
Sep-29-16 03:25PM  INSPIREMD, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Change in Directors or Princ -11.76%
Sep-28-16 04:01PM  InspireMD Announces 1-for-25 Reverse Stock Split Marketwired
Sep-08-16 10:07AM  INSPIREMD, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and
Sep-07-16 07:00AM  InspireMD Appoints Thomas Kester to Board of Directors Marketwired
Aug-12-16 11:45AM  InspireMD, Inc. :NSPR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-10-16 05:06PM  INSPIREMD, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Aug-09-16 04:24PM  INSPIREMD, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -7.60%
04:01PM  InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 Marketwired
Aug-02-16 07:00AM  InspireMD to Report Second Quarter Financial Results on Tuesday, August 9, 2016 Marketwired
Aug-01-16 10:12AM  UPDATE - InspireMD Announces Listing of Warrants on the NYSE MKT Marketwired
Jul-29-16 02:55PM  INSPIREMD, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jul-21-16 05:29PM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:05PM  InspireMD Regains Compliance With NYSE MKT Listing Standards Marketwired
Jul-15-16 07:46AM  INSPIREMD, INC. Files SEC form 8-K, Other Events
Jul-08-16 06:05AM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -12.48%
Jul-07-16 05:30PM  InspireMD Announces Closing of Public Offering of Approximately $14.6 Million Marketwired
Jul-05-16 09:57AM  Platinum Partners to Shut Down Main Fund; Here Are Its 5 Stock Picks at Insider Monkey -10.26%
Jul-01-16 02:26PM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -19.91%
Jun-30-16 08:41PM  CORRECTION - InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million Marketwired -12.33%
07:40PM  InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million Marketwired
Jun-14-16 12:55PM  INSPIREMD, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga
08:00AM  InspireMD Announces Amendment to Loan & Security Agreement With Hercules Capital Marketwired
Jun-07-16 03:19PM  INSPIREMD, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and
08:00AM  InspireMD Names Dr. James Barry as President and CEO Marketwired
Jun-01-16 12:37PM  InspireMD, Inc. :NSPR-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-25-16 02:26PM  INSPIREMD, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Change in Directors or Princ +16.67%
May-17-16 01:09PM  INSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -17.12%
08:00AM  InspireMD's CGuard(TM) Highlighted at the Late-Breaking Clinical Trial Session at the EuroPCR 2016 Conference Marketwired
May-10-16 12:29PM  INSPIREMD, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:30AM  InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 Marketwired
May-05-16 08:00AM  InspireMD Announces Late-Breaking Trial Presentation on CGuard(TM) Embolic Prevention System at EuroPCR 2016 Conference Marketwired
Apr-19-16 11:56AM  INSPIREMD, INC. Files SEC form 8-K, Other Events
Apr-07-16 09:14AM  4 Growth Stocks to Buy Near Their 52-Week Lows +6.00%
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing NVGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.